Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.
about
New disturbing trend in antimicrobial resistance of gram-negative pathogensCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsCefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.Overcoming antimicrobial resistance by targeting resistance mechanisms.Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria.Mechanisms of bacterial biocide and antibiotic resistance.Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.Insights into mechanisms and proteomic characterisation of Pseudomonas aeruginosa adaptation to a novel antimicrobial substanceIn vitro and in vivo activities of AM-112, a novel oxapenem.Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102.Efflux pumps of the resistance-nodulation-division family: a perspective of their structure, function, and regulation in gram-negative bacteria.Resistance to beta-lactams--the permutations.Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.Bacterial efflux pump inhibitors from natural sources.Structural and functional aspects of the multidrug efflux pump AcrB.Promoter sequences necessary for high-level expression of the plasmid-associated ampC beta-lactamase gene blaMIR-1.In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.Antimicrobial resistance in the food chain: a review.Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodImpact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.Diversity of extended-spectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli Isolates in Belgian broiler farms.Occurrence of Plasmid-Mediated AmpC β-Lactamases Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Tertiary Care Hospital in Bangalore.Comparision of Three Laboratory Tests for Detection of AmpC β Lactamases in Klebsiella Species and E. ColiAntimicrobial activities of some mushrooms in Turkey.A fluorescein-labeled AmpC β-lactamase allows rapid characterization of β-lactamase inhibitors by real-time fluorescence monitoring of the β-lactamase-inhibitor interactions.Screening of Brazilian basidiomycetes for antimicrobial activity
P2860
Q33422956-0362B4A7-C76A-4836-AE07-45AC013998DBQ33659230-AAC496FA-FD0F-4C4D-B52C-B853C4BCB60FQ33983667-73C34815-C227-465D-88F7-F224A467FC12Q34211132-969439D8-427B-4344-9A5E-EFD3C67F3498Q34259762-9C77CD98-4C36-4D10-9532-EDA784CC5756Q34631438-F7DD9018-A6BF-41EB-92A5-BA92D7AD934CQ34680522-368AA24C-231F-4847-B43F-6DE89D748967Q34837464-14398BC3-1820-40E8-994B-8B1F8C44CBBAQ34938276-E1BBB4A4-D643-4279-8144-F65D998C1504Q35166203-BF530CF6-EBEF-4962-AD88-B4B78E6B6357Q35329956-B3C28834-F3E6-47D8-B875-C6DCAB4A844BQ35681127-0270C969-360A-4C45-BF0B-B47B5ADECC6CQ35906971-6521160E-20DC-45B2-96E0-F113137EBBA1Q35917401-09783BB2-6910-4118-B7F6-4DA284BC80DCQ36673618-57F4759F-0F22-40C1-B934-D026D6119119Q37488259-CFE13CEE-9DC1-4F3B-A9E1-E03249C9A08AQ37598665-066AF03E-9110-42EB-AE1F-5C482202C0FCQ37624562-35E611DA-325A-4D50-A7CE-EBD9DB92956DQ38118080-BBC27AA6-0918-4C49-8F09-A5AD5B22124AQ38454462-56C551BC-711F-4ACD-B427-F31F5EE39E06Q39664817-BC1E1C48-8AC5-4AB0-B4C7-8902C185D79CQ39671146-D6A9A36F-BFFB-4A00-BF44-044A979B6925Q39773769-B1FE5071-DF74-4E83-9151-2C1E2D041EF2Q39792561-7FD4B347-D862-4B6F-9AAA-086E97E53465Q41142049-8A758496-7C83-4338-B682-9EB679C0C422Q42112001-45D35352-DEB8-477A-971C-64FA00CAB2E7Q42201691-153B5380-BECC-4DF2-9833-9E148C66900FQ42783545-D3B6CC43-3B0E-4997-BF37-FCB90026F4A5Q43626583-B05B32B5-8AB8-4D22-95DB-21F1842AE6C1Q53392951-6CDC53F0-84DB-429C-9837-81D3D68EACD4Q58860449-B4BA4F16-5EB6-4FFC-B955-BF5719174694
P2860
Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@ast
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@en
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@nl
type
label
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@ast
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@en
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@nl
prefLabel
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@ast
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@en
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@nl
P1476
Version 2000: the new beta-lac ...... he dawn of the new millennium.
@en
P2093
E Smith Moland
K S Thomson
P304
P356
10.1016/S1286-4579(00)01276-4
P577
2000-08-01T00:00:00Z